Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Member Company Press Release

OBN and its Investment & Tax Special Interest Group (ITSIG) issues an Open Letter to the Chancellor for a better deal for the Life Sciences sector

OBN and its Investment & Tax Special Interest Group (ITSIG) issues an Open Letter to the Chancellor for a better deal for the Life Sciences sector:

 

Read the rest of entry »

The Oxford Science Park: Immunometabolism company Sitryx expands into new space at TOSP

Sitryx, a company which is focused on regulating cell metabolism to develop disease-modifying therapeutics in inflammatory diseases and immuno-oncology, announces that it has expanded into new premises in the Bellhouse Building at The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies.

Read the rest of entry »

The Oxford Trust: £0.5 million Headington life science laboratory development at The Oxford Trust’s Innovation Centre supported by funding secured by OxLEP

The Oxford Trust, the local charity encouraging the pursuit of science and enterprise, is to undertake a half million-pound project to install life science laboratory facilities at its Wood Centre for Innovation in Headington, Oxford, to increase capacity for the local innovation ecosystem and has received £0.1 million in funding towards the project via the Government’s Local Growth Fund, secured by the Oxfordshire Local Enterprise Partnership (OxLEP).

 

Read the rest of entry »

Milton Park: Emergex Vaccines expands at Milton Park

Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats such as COVID-19, Dengue fever, Zika, Ebola and pandemic Flu, has expanded at Milton Park in Oxfordshire, one of Europe’s largest science and technology communities.

Read the rest of entry »

AMSBIO: Breast Cancer Cell Line Array 

AMSBIO announce a new HER2 control cell line array that was developed and is proven as an effective slide quality control for HER2 expression in breast cancer tissue samples.

This new FFPE cell pellet microarray delivers a full dynamic range of HER2, ER and PR expression, validated by the Ventana system, to give immunohistochemical data in strong concordance with the routinely processed tissue sample.sections.

Read the rest of entry »

ChromoTek and Absolute Antibody Collaborate on Recombinant Engineered Antibodies

ChromoTek GmbH, part of Proteintech specializing in Nanobody-based reagents, and Absolute Antibody Ltd., a leading provider of recombinant antibody technology, today announced a partnership to offer recombinant engineered antibodies to scientists worldwide. The chimeric antibodies were originally derived from alpaca Nanobodies and engineered onto mouse and rabbit Fc domains to open up new research applications. Available antibodies target key fluorescent proteins commonly used as tags for protein visualization, as well as the structural protein vimentin.

Read the rest of entry »

Psyros: NHSEI SBRI Healthcare grant for Psyros’ rapid, ultra-sensitive test for heart attack marker Firm raising £2.5m seed round to support further development of prototype

Psyros Diagnostics, which is developing ultra-sensitive, ultra-fast, point of care diagnostics based on single molecule counting, has been awarded a £99,400 grant by NHSEI SBRI Healthcare1 to advance their novel test for the heart attack marker troponin.

Read the rest of entry »

Arctoris unveils expanded next-generation robotic platform ahead of company anniversary

Arctoris, an Oxford-based technology company operating a fully automated drug discovery platform, celebrated its 5th anniversary on the 4th of February. Over the past five years, Arctoris has grown from a technology startup to a globally operating company delivering integrated drug discovery projects with partners on three continents from its headquarters in Oxford and its Asia-Pacific hub in Singapore. On the occasion of its 5th anniversary, Arctoris unveiled its new and expanded, next-generation robotic platform, Ulysses.

Read the rest of entry »

Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization

Feb. 9, 2021 – Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide.

Read the rest of entry »

Vaccitech Doses First Patient in HBV002, a Phase 1b/2a Clinical Trial of VTP300 immunotherapeutic candidate for Chronic HBV Patients

Oxford, UK – 1st February 2021 – Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the dosing of the first patient in HBV002.

Read the rest of entry »

Pages: Previous1234567NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.